L04.1 – Clinical Trials in LATAM

As the clinical supply chain landscape becomes increasingly global and complex, Latin America (LATAM) has emerged as a high-potential frontier for sponsors seeking diversity, cost-efficiency, and rapid recruitment. However, navigating the “LatAm Labyrinth” requires more than just a map; it requires a deep understanding of evolving regulatory frameworks, localized logistics, and the cultural nuances of patient engagement. This session provides a comprehensive look at the state of clinical trials in Latin America in 2026. We will dive into the recent regulatory harmonization efforts across major hubs like Brazil, Mexico, and Argentina, and discuss how decentralized clinical trial (DCT) technologies are bridging the gap between urban centers and remote populations. Participants will gain insights into the “hidden” hurdles of import/export compliance and temperature-controlled distribution in a region known for its diverse climates and infrastructure challenges. Whether you are considering your first trial in the region or looking to optimize an existing program, this lecture offers the strategic toolkit needed to succeed in the LATAM market.